UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000010680
Receipt No. R000012227
Scientific Title Evaluation of the Chiba alliance medical path-stroke (Durg sheet)
Date of disclosure of the study information 2013/05/09
Last modified on 2016/05/13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Evaluation of the Chiba alliance medical path-stroke (Durg sheet)
Acronym Evaluation of the Chiba alliance medical path-stroke (Durg sheet)
Scientific Title Evaluation of the Chiba alliance medical path-stroke (Durg sheet)
Scientific Title:Acronym Evaluation of the Chiba alliance medical path-stroke (Durg sheet)
Region
Japan

Condition
Condition Stroke
Classification by specialty
Medicine in general Endocrinology and Metabolism Neurosurgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We evaluate the Chiba alliance medical path-stroke (drug sheet).
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Control item of Stroke patients
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients' use of the Chiba alliance medical path-stroke (drug sheet)
Key exclusion criteria Not applicable
Target sample size 160

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Hisashi IIJIMA
Organization Chiba Pharmaceutical Association
Division name Drug Information Center
Zip code
Address 9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba, 260-0025 Japan
TEL 043-247-4401
Email

Public contact
Name of contact person
1st name
Middle name
Last name Hisashi IIJIMA
Organization Chiba Pharmaceutical Association
Division name Drug Information Center
Zip code
Address 9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba 260-0025, Japan
TEL 043-247-4401
Homepage URL
Email drug-info@c-yaku.or.jp

Sponsor
Institute Chiba Pharmaceutical Association
Institute
Department

Funding Source
Organization Chiba Pharmaceutical Association
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 05 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Age of study patients were 66.2 years and 38.2% for modified Rankin Scale 4. period between draw up and B obtain of drug sheet was 11.0 days, obtain and use was 3.1 days.
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 03 Month 12 Day
Date of IRB
Anticipated trial start date
2013 Year 05 Month 01 Day
Last follow-up date
2014 Year 10 Month 31 Day
Date of closure to data entry
2015 Year 04 Month 01 Day
Date trial data considered complete
2015 Year 04 Month 01 Day
Date analysis concluded
2015 Year 06 Month 01 Day

Other
Other related information Observation of general treatment at drug sheet

Management information
Registered date
2013 Year 05 Month 09 Day
Last modified on
2016 Year 05 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012227

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.